These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34253850)

  • 1. Potential for transmission of sporadic Creutzfeldt-Jakob disease through peripheral routes.
    Kobayashi A; Munesue Y; Shimazaki T; Aoshima K; Kimura T; Mohri S; Kitamoto T
    Lab Invest; 2021 Oct; 101(10):1327-1330. PubMed ID: 34253850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
    Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
    J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prion protein with valine 129 prevents expression of variant CJD phenotype.
    Wadsworth JD; Asante EA; Desbruslais M; Linehan JM; Joiner S; Gowland I; Welch J; Stone L; Lloyd SE; Hill AF; Brandner S; Collinge J
    Science; 2004 Dec; 306(5702):1793-6. PubMed ID: 15539564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.
    Hizume M; Kobayashi A; Teruya K; Ohashi H; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2009 Feb; 284(6):3603-9. PubMed ID: 19074151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients.
    Douet JY; Huor A; Cassard H; Lugan S; Aron N; Mesic C; Vilette D; Barrio T; Streichenberger N; Perret-Liaudet A; Delisle MB; Péran P; Deslys JP; Comoy E; Vilotte JL; Goudarzi K; Béringue V; Barria MA; Ritchie DL; Ironside JW; Andréoletti O
    Acta Neuropathol Commun; 2021 Aug; 9(1):145. PubMed ID: 34454616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
    Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T
    Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
    Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
    PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a quick bioassay for the evaluation of transmission properties of acquired prion diseases.
    Munesue Y; Shimazaki T; Qi Z; Isoda N; Sawa H; Aoshima K; Kimura T; Mohri S; Kitamoto T; Kobayashi A
    Neurosci Lett; 2018 Mar; 668():43-47. PubMed ID: 29329906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.
    Klemm HM; Welton JM; Masters CL; Klug GM; Boyd A; Hill AF; Collins SJ; Lawson VA
    J Biol Chem; 2012 Oct; 287(43):36465-72. PubMed ID: 22930754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.
    Asante EA; Linehan JM; Desbruslais M; Joiner S; Gowland I; Wood AL; Welch J; Hill AF; Lloyd SE; Wadsworth JD; Collinge J
    EMBO J; 2002 Dec; 21(23):6358-66. PubMed ID: 12456643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic and familial CJD: classification and characterisation.
    Gambetti P; Kong Q; Zou W; Parchi P; Chen SG
    Br Med Bull; 2003; 66():213-39. PubMed ID: 14522861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
    Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
    Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Evidence for a Causal Link between Bovine Spongiform Encephalopathy Strain Variant L-BSE and Known Forms of Sporadic Creutzfeldt-Jakob Disease in Human PrP Transgenic Mice.
    Jaumain E; Quadrio I; Herzog L; Reine F; Rezaei H; Andréoletti O; Laude H; Perret-Liaudet A; Haïk S; Béringue V
    J Virol; 2016 Dec; 90(23):10867-10874. PubMed ID: 27681129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.
    Bishop MT; Diack AB; Ritchie DL; Ironside JW; Will RG; Manson JC
    Brain; 2013 Apr; 136(Pt 4):1139-45. PubMed ID: 23449776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iatrogenic Creutzfeldt-Jakob disease.
    Kobayashi A; Kitamoto T; Mizusawa H
    Handb Clin Neurol; 2018; 153():207-218. PubMed ID: 29887137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.